Shah says the industry is witnessing significant changes
Artificial intelligence (AI) and machine learning (ML) are being adapted in the healthcare industry along with other technological advancements taking place that assist in enhancing the potential of workforce.
This insight was given by Manan Shah who is currently a consultant with the Covid-19 vaccine pioneer biotech company, Pfizer, and holds extensive experience of working with global health authorities and institutions in regulating the medicine market.
“AI and ML are also being used to improve diagnosis, treatment and patient outcomes. These applications in healthcare range from drug discovery to medical imaging analysis, helping healthcare providers make better decisions and improving medical outcomes for patients,” he said in a release on 12 June 2023.
Other technological advancements range from services to research to the adaptation of AI in the medical field.
Advances in genomics and data analysis enable healthcare providers to diagnose and treat diseases more accurately, tailoring treatments to individual patient needs.
Furthermore, Gene and cell therapies represent another exciting area of research, offering the possibility of treating once-incurable diseases.
More gene and cell therapies are expected to hit the market in the coming years, leading to a paradigm shift towards precision medicine, as per the expert.
While emerging trends in the healthcare industry are not restricted to the aforementioned aspects, they represent some of the most significant changes that the industry is witnessing.
As such, biotech, pharmaceutical, and medical device companies are feeling the need to invest in research and development to stay at the forefront of healthcare innovation while catering to the ever-evolving horizon, according to Shah.
He also noted on the importance of emerging collaborative approaches amongst health authorities, biopharmaceutical companies and other stakeholders.
“Communication channels have opened up, allowing for instant dissemination of information and regulatory updates, facilitating faster clinical trials, emergency use authorizations, and ultimately, the development and distribution of vaccines and therapies to combat several issues,” he stated. Fiinews.com
